Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Emerging risks | Growth Opportunities | APAC Insurance

Monday, May 5, 2025
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Emerging risks | Growth opportunities | APAC insurance

Monday, 5 May 2025
Linkedin
Newsletter
Free trial
Subscribe
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Dedicated hubs

Life and Health
LifeandHealth_Menuwebp
Cyber
Cyber_Menuwebp
Energy
EnergyMenuwebp
Marine
MarineMenuwebp
Regulation
RegulationMenuwebp
Capital management
CapitalMenu
Nat cat
NatCatMenu

Browse content

Report: China Life invests US $42.4m in Series B round for Yingke Biopharmaceutic

Yingke was established in 2022 and is engaged in the R&D of pharmaceutical drugs
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

Editorial team

THIS PREMIUM INSIGHT IS FOR SUBSCRIBERS ONLY.

Stay ahead with precise, independent journalism of APAC's insurance markets.

Unlocked access today:

Already subscribed? Log in using the form below or click here

Share this article

Read next

Peak Re on Black Kite II-a closer look at the multi-peril multi-territory cat bond
global-data-projects-new-zealand-life-insurance-market-to-reach-us4-73bn-by-2029
regulatory-reforms-to-drive-growth-in-malaysias-non-life-insurance-market-am-best
marine-insurance-underwriters-adopt-cautious-approach-as-tariffs-fuel-market-uncertainty
amid-slower-general-insurance-growth-indias-smaller-players-surge
chinas-non-life-insurance-could-face-rising-claims-slower-growth-from-us-tariffs-globaldata
pacific-region-records-largest-global-commercial-rate-fall-for-second-quarter-running-marsh
indias-gi-market-projected-to-grow-13-in-fy2026-india-ratings
chinas-solvency-rules-reshape-asian-life-insurers-strategies
south-korean-motor-insurance-market-anticipated-to-exceed-us19bn-by-2028
Report china life invests us 4m in series b round for yingke biopharmaceutic rein asia

© Playfair Media 2024

17/F, 80 Gloucester Road, Wan Chai, Hong Kong